[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-365202-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-365202-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","slc25a19-is-a-key-prognostic-marker-for-hepatocellular-carcinoma","SLC25A19 is a key prognostic marker for hepatocellular carcinoma","","SLC25A19 mediates thiamine pyrophosphate (TPP) transport across cell membranes, yet its role in cancer is not well defined. This study performs a pan-cancer analysis using RNA-seq, survival, and clinicopathological data from TCGA to assess expression and outcome associations. In hepatocellular carcinoma (HCC), SLC25A19 is overexpressed and linked to poor prognosis, and higher levels correlate with immune checkpoint gene expression, suggesting a potential immunotherapy relevance. PCR and Western blot validation show upregulated SLC25A19 in HCC versus adjacent normal tissues, supporting diagnostic and treatment reference value.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/slc25a19-is-a-key-prognostic-marker-for-hepatocellular-carcinoma/365202/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/slc25a19-is-a-key-prognostic-marker-for-hepatocellular-carcinoma/365202.png","ImageObject",300,407,{"name":42,"@type":43},"Margaret","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-31","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What biological function of SLC25A19 is investigated in relation to cancer?","Question",{"text":63,"@type":64},"SLC25A19 transports thiamine pyrophosphate (TPP) across cell membranes. TPP supports metabolic enzyme cofactors and cellular homeostasis, motivating evaluation of SLC25A19 as a cancer-relevant target.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How is SLC25A19 associated with outcomes in hepatocellular carcinoma?",{"text":68,"@type":64},"In HCC, SLC25A19 is overexpressed and correlates with poor prognosis, indicating prognostic value.",{"name":70,"@type":61,"acceptedAnswer":71},"What evidence links SLC25A19 to the immune microenvironment in HCC?",{"text":72,"@type":64},"High SLC25A19 expression in HCC aligns with high expression of immune checkpoint genes, implying a possible role in immunotherapy strategies.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},365202,1790640340,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},137451207643,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nSLC25A19 is a key prognostic marker for hepatocellular carcinoma  \nLiang Chen1,5, Xiaomei Ying2,5, Jiaheng Xie3,5, Hong Liu4,5 & Wen Liu1􀀍  \nSLC25A19 is a protein that mediates the transport of thiamine pyrophosphate (TPP) across cell membranes, but its significance in cancer remains largely unknown. To address this knowledge gap, we conducted a pan-cancer analysis to investigate the role ofSLC25A19 in cancer. To investigate the role ofSLC25A19 in cancer, we obtained RNA-seq, survival, and clinicopathological data from 33 cancers in theTCGA database. We performed expression and survival analyses ofSLC25A19 across these cancers. Additionally, we explored the diagnostic and prognostic value ofSLC25A19 specifically in hepatocellular carcinoma (HCC). To understand the potential role ofSLC25A19 in the immune microenvironment of HCC, we also analyzed its expression in relation to immune checkpoint genes. Then we identified the drug most strongly correlated with SLC25A19 expression in HCC. Finally, PCRand Western-Blotting experiments were performed on HCC and its paracancer tissues to verify the expression ofSLC25A19 . Our analysis revealed that SLC25A19 is overexpressed in hepatocellular carcinoma (HCC) and is associated with poor prognosis. We also found that high expression of SLC25A19 in HCC is associated with high expression of immune checkpoint genes, suggesting a potential role for SLC25A19 in immunotherapy. Furthermore, we identified drugs that are most strongly correlated with SLC25A19 expression in HCC, which could inform treatment decisions for HCC patients. PCR results showed that the expression ofSLC25A19 in HCC was significantly up-regulated in 6 pairs of HCC and adjacent normal tissues. Our study can provide a reference for the diagnosis and treatment of HCC.  \nKeywords Cancer metabolism, Solute carrier, Thiamine pyrophosphate, SLC25A19, Hepatocellular carcinoma  \nAbbreviations  \nLAML Acute myeloid leukemia  \nACC Adrenocortical carcinoma  \nCHOL Cholangio carcinoma BLCA Bladder urothelial carcinoma BRCA Breast invasive carcinoma  \nCESC Cervical squamous cell carcinoma and endocervical adenocarcinoma COAD Colon adenocarcinoma  \nUCEC Uterine corpus endometrial carcinoma  \nESCA Esophageal carcinoma GBM Glioblastoma multiforme  \nHNSC Head and neck squamous cell carcinoma KICH Kidney chromophobe  \nKIRC Kidney renal clear cell carcinoma KIRP Kidney renal papillary cell carcinoma  \nDLBC Lymphoid neoplasm diffuse large B-cell lymphoma LIHC Liver hepatocellular carcinoma  \n1Department of Hepatobiliary and Pancreatic Surgery, Conversion Therapy Center for Hepatobiliary and Pancreatic Tumors, First Hospital of Jiaxing, Affiliated Hospital of Jiaxing University, Jiaxing, Zhejiang, People’s Republic of China. 2Department of General Surgery, Suzhou Hospital of Anhui Medical University, Hefei, China. 3Department of Plastic Surgery, Xiangya Hospital, Central South University, Changsha, China. 4Department of Cardiovascular Medicine, Fuyang Hospital of Anhui Medical University, Fuyang, China. 5Liang Chen, Xiaomei Ying, Jiaheng Xie and Hong Liu contributed equally. 􀀍 email: [nickwen2006@163.com](nickwen2006@163.com)  \n[www. nature.com/scientificreports/](www. nature.com/scientificreports/)  \nLGG Brain lower grade glioma LUAD Lung adenocarcinoma LUSC Lung squamous cell carcinoma SKCM Skin cutaneous melanoma  \nMESO Mesothelioma UVM Uveal melanoma  \nOV Ovarian serous cystadenocarcinoma  \nPAAD Pancreatic adenocarcinoma  \nPCPG Pheochromocytoma and paraganglioma  \nPAD Prostate adenocarcinoma  \nREAD Rectum adenocarcinoma SARC Sarcoma  \nSTAD Stomach adenocarcinoma TGCT Testicular germ cell tumors  \nTHYM Thymoma  \nTHCA Thyroid carcinoma USC Uterine carcinosarcoma  \nMetabolic reprogramming is a well-established hallmark of cancer that involves changes in glucose, amino acid, lactic acid, and nucleotide metabolism, among other processes1–3. Cancer cells require high meta","cbCaifjwdI1vc8jI","https://ap.wps.com/l/cbCaifjwdI1vc8jI","pdf",5153999,14,"English","# Background\n# Pan-cancer analysis approach\n# Findings in hepatocellular carcinoma (HCC)\n## Prognostic association\n## Immune microenvironment and checkpoint linkage\n# Experimental validation\n## PCR and Western blot results\n# Clinical implications","[{\"question\":\"What biological function of SLC25A19 is investigated in relation to cancer?\",\"answer\":\"SLC25A19 transports thiamine pyrophosphate (TPP) across cell membranes. TPP supports metabolic enzyme cofactors and cellular homeostasis, motivating evaluation of SLC25A19 as a cancer-relevant target.\"},{\"question\":\"How is SLC25A19 associated with outcomes in hepatocellular carcinoma?\",\"answer\":\"In HCC, SLC25A19 is overexpressed and correlates with poor prognosis, indicating prognostic value.\"},{\"question\":\"What evidence links SLC25A19 to the immune microenvironment in HCC?\",\"answer\":\"High SLC25A19 expression in HCC aligns with high expression of immune checkpoint genes, implying a possible role in immunotherapy strategies.\"}]","SLC25A19 is a key prognostic marker for hepatocellular carcinoma | PDF",1790160347,35,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/77875ddea7819956d53eaaff8b5c32b0.webp",983,1291,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9d7264c3a4460aa0430643c2d44b446a.webp",982,1290,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c43e5d5a7c29ce85642d01a42111aeda.webp",981,1289,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/621c8f4b0bd5b0eb1b2f282326512237.webp",980,1287]